Category: Blood Diseases
Global Blood Diseases
-
2024 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Analysis & Forecasts
... share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The historical data ... Read More
-
Bleeding Disorders Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global bleeding disorders market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global bleeding ... Read More
-
Global Cell and Gene Therapy Market Size Study, by Therapy Type (Cell Therapy, Gene Therapy), by Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders, Others) and Regional Forecasts 2022-2032
... and Gene Therapy Market was valued at approximately USD 12.62 billion in 2023 and exhibiting a compound annual growth rate (CAGR) of 18.04% during the forecast period 2024-2032. Cell and gene therapy are advanced medical ... Read More
-
Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) - Global Forecast to 2029
... Forecast to 2029 The global hematology analyzers and reagents market is projected to reach USD 8.8 billion by 2029 from USD 6.6 billion in 2024, growing at a CAGR of 6.1% during the forecast period. ... Read More
-
2024 Global Forecast for Sickle Cell Disease Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Global Anti-thrombin III Testing Market 2024-2028
... forecast period. The report on the anti-thrombin III testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Rare Hemophilia Factors Market 2024-2028
... forecast period. The report on the rare hemophilia factors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Plasma Fractionation Market Research Report Data by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030
... Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030 In 2023, the ... Read More
-
Drugs and Diagnostics for Hematological Disorders: Global Markets
... diseases. Based on product type, the diagnostic market for hematological disorders is divided into reagents & instruments and software. By end user, the market is segmented into hospitals, diagnostic labs, and others. On the basis ... Read More
-
Global Iron-Deficiency Anemia Therapy Market
... period of 2024 to 2031. Market Segmentation: Global Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy and Oral Iron Therapy), Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel ... Read More
-
2024 Global: Hemophilia Treatment Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028
... on the autoimmune hemolytic anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Iron Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Sickle Cell Anemia Therapeutics Competitive Landscape Professional Research Report 2024
... a genetic disorder characterized by abnormal hemoglobin production. Therapeutic approaches for sickle cell anemia may include disease-modifying medications such as hydroxyurea, which increases fetal hemoglobin production and reduces the frequency of painful vaso-occlusive crises. Other ... Read More
-
Global Hemophilia Gene Therapy Competitive Landscape Professional Research Report 2024
... Typically, hemophilia gene therapy involves introducing a functional copy of the clotting factor gene into the patient＇s cells, often using viral vectors as delivery vehicles. The goal is to enable the patient＇s cells to produce ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.04 billion in 2024, at a CAGR 6.10% to reach USD 8.63 billion by 2030. The hemoglobin testing market comprises various diagnostic products, services, and technologies that healthcare ... Read More
-
Sickle Cell Anemia Testing & Screening Market by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests), Age Group (Adult Screening, Newborn Screening, Years 1 to 25), Sector - Global Forecast 2024-2030
... Anemia Testing & Screening Market size was estimated at USD 943.95 million in 2023 and expected to reach USD 1,070.69 million in 2024, at a CAGR 13.51% to reach USD 2,293.22 million by 2030. Sickle ... Read More
-
Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The global sickle cell disease treatment market encounters numerous challenges that impede its revenue growth. These challenges stem from inadequate healthcare infrastructure, unavailability of drugs in rural regions, lack of reimbursement, high treatment costs, ... Read More
-
2024 Global Forecast for Plasma Fractionation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Rare Hemophilia Factors Databank Market Report
... 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. ... Read More
-
Global Hematologic Malignancies Databank Market Report
... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More
-
Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030
... genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030
... caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels ... Read More
Research Assistance
